Navigation Links
Certain new therapies for age-related eye disease do not appear to increase heart risks
Date:10/11/2010

Newer treatments for age-related macular degeneration (AMD)including an intravitreous (into the eye) injection of a chemotherapy drug and use of a related compound approved for use against the eye diseasedo not appear to be associated with an increased risk of cardiovascular complications or death when compared with existing therapies, according to a report in the October issue of Archives of Ophthalmology, one of the JAMA/Archives journals.

"More than 1.5 million older Americans have age-related macular degeneration, the most common cause of irreversible vision loss among older patients," the authors write as background information in the article. Of these, 12 percent have neovascular disease, which occurs when new blood vessels form in the eye and accounts for more than 80 percent of cases of severe vision loss. Before June 2006, there were two approved therapies for this condition, both of which slow vision loss but usually do not improve visual acuity: photodynamic (laser) therapy in combination with the photosensitizing medication verteporfin, and eye injections with pegaptanib octasodium, a nucleic blocking abnormal blood vessel growth.

By the fall of 2005, ophthalmologists began treating AMD with the cancer drug bevacizumab, an antibody that also blocks blood vessel growth. In June 2006, ranibizumaban antibody fragment with a similar mechanismwas approved by the Food and Drug Administration for treatment of AMD. "In chemotherapy regimens, bevacizumab is associated with an increased risk of thromboembolic events," when a blood clot forms and travels through blood vessels, potentially causing a stroke or heart attack, the authors write. "However, intravitreous bevacizumab is administered at a dose of 1 to 2.5 milligrams, 150 times less than the systemic dose. Despite the regulatory approval of ranibizumab, off-label use of bevacizumab continues, likely because of the cost difference ($1,950 per dose of ranibizumab vs. $30 per dose
'/>"/>

Contact: Debbe Geiger
Debbe.Geiger@duke.edu
919-660-9461
JAMA and Archives Journals
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Certain genetic profiles associated with recurrence-free survival for non-small cell lung cancer
2. Certain pain medications do not appear to be associated with skin cancer risk
3. AGA offers new recommendations for CRC surveillance for certain patients with IBD
4. Smoking significantly increases risk of aneurysm in people with certain genes
5. American Stroke Association Late-Breaking Science Report: Surgery, Stenting to Open Blocked Neck Arteries Similar in Safety, Efficacy, But Show Differences in Stroke, Heart Attack and Death Rates at Certain Ages
6. Certain Bone Drugs May Lower Breast Cancer Risk
7. Football Injuries More Likely on Certain Artificial Turf
8. Plavix Can Help Cut Death Risk in Certain Heart Patients
9. The Worst Is Over, but the Road to Growth Is Uncertain - The 17th Annual CFO Rising Conference & Exhibition
10. Perhaps a longer lifespan, certainly a longer health span
11. One in Five Parents Would Spank in Certain Settings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... the children at Father’s Home come from different backgrounds ... to mar their respective psychosocial development. There appears to ... has underpinnings in a healthy adolescence and in this ... foreseeable future, would assist in developing the youth. , ... of Foundation members in that remote location – as ...
(Date:7/30/2014)... Kathleen Doheny HealthDay ... Dieting at a young age might set the stage for ... Surveys of college-age women conducted from 1982 to 2012 ... and alcohol abuse. "The younger a woman was when ... [later] to use extreme weight control behaviors -- like vomiting ...
(Date:7/30/2014)... Dennis Thompson HealthDay Reporter ... fruits and vegetables are vital to good health and a ... hit five servings of fruits and vegetables each day, additional ... review suggests. The human body may only be able ... every day, limiting its ability to absorb important nutrients from ...
(Date:7/30/2014)... (USP) have identified an RNA known as INXS that, ... protein, modulates the action of an important gene in ... , According to Sergio Verjovski-Almeida, professor at the USP ... So Paulo Research Foundation (FAPESP), INXS expression is generally ... of stimulating the production of this non-coding RNA can ...
(Date:7/30/2014)... Florida A&M University ( FAMU ) ... professor Ngozi Ugochukwu, Ph.D., will head to Nigeria ... The prestigious Fulbright Scholars Program is a highly ... to students, faculty or professionals who wish to ... and Ugochukwu will conduct respective research on the ...
Breaking Medicine News(10 mins):Health News:The Edusei Foundation Donates Food and Assorted Items to the Fathers’ Home Care Ministries in Takoradi, Ghana 2Health News:Dieting at Young Age Often Backfires, Study Says 2Health News:Dieting at Young Age Often Backfires, Study Says 3Health News:Fruits, Veggies May Have Their Limits in Boosting Lifespan 2Health News:Fruits, Veggies May Have Their Limits in Boosting Lifespan 3Health News:Brazilian researchers identify RNA that regulates cell death 2Health News:Brazilian researchers identify RNA that regulates cell death 3Health News:FAMU Professor and Engineering Student Named Fulbright Scholars 2Health News:FAMU Professor and Engineering Student Named Fulbright Scholars 3
... useless, the appendix now appears to have a reason to ... living in the human gut. , Drawing upon a series ... that the beneficial bacteria in the appendix that aid digestion ... the intestines and emerge afterwards to repopulate the gut. Their ...
... insights into chronic, illnesses, including heart failure and COPD, from ... ... Calif., Oct. 8 VivoMetrics announced today,that noted researcher Bruce D. Johnson, ... LifeShirt(R) System to,the South Pole to collect valuable data for his ongoing ...
... Prescription Pads with ... Enhanced Patient Features, HASBROUCK ... prescription pads, today announced that,it has appointed Richard Zwickel to ... model. Being launched this,month at the PDMA Sharing Conference in ...
... mothers who survived ... breast cancer, ALPHARETTA, Ga., ... brand, celebrates the "Power of Pink" by,announcing the winners of its "Pink ... women will be recognized,during the Susan G. Komen for the Cure Pink ...
... scrapes and bruises, study found , MONDAY, Oct. 8 (HealthDay ... as a non-lethal way to incapacitate suspects, are generally safe ... say U.S. researchers who reviewed almost 1,000 incidents involving the ... to a Taser had mild injuries (such as scrapes and ...
... to More Than Half the Population of Singapore to Use ... ... Facilities -, BOCA RATON, Fla., ... today announced,that SingHealth, the largest healthcare provider in Singapore, has selected,Eclipsys ...
Cached Medicine News:Health News:Appendix isn't useless at all: It's a safe house for bacteria 2Health News:Appendix isn't useless at all: It's a safe house for bacteria 3Health News:VivoMetrics' LifeShirt Going to South Pole to Uncover Clues to High-Altitude Illness 2Health News:VivoMetrics' LifeShirt Going to South Pole to Uncover Clues to High-Altitude Illness 3Health News:Medi-Promotions Hires Industry Executive to Expand its Medi-Scripts Prescription Pad Model 2Health News:'Pink Power Moms' Unite in Atlanta for Day of Pampering and Recognition 2Health News:'Pink Power Moms' Unite in Atlanta for Day of Pampering and Recognition 3Health News:'Pink Power Moms' Unite in Atlanta for Day of Pampering and Recognition 4Health News:Serious Injury Rare With Police Tasers 2Health News:SingHealth Selects Eclipsys Solutions to Help Improve Clinical Outcomes, First Sunrise Clinical Manager Client Outside of North America 2Health News:SingHealth Selects Eclipsys Solutions to Help Improve Clinical Outcomes, First Sunrise Clinical Manager Client Outside of North America 3
(Date:7/30/2014)... , July 30, 2014 Silicon Valley Bank, ... a study today that examines the merger, acquisition ... device companies.  According to the annual report based on ... potential returns since SVB started tracking the data in ... IPO.  Built on solid healthcare M&A activity over the ...
(Date:7/30/2014)... NEW YORK , July 30, 2014 ... products for oncology supportive care, announced that its novel ... featured in an article on OncLive.com titled, "Study Finds ... Neck Cancers."  Dr. Steve Sonis , a leading ... demand seen in the oncology community for evidence-based strategies ...
(Date:7/30/2014)...   Medical Equipment Solutions, Corp. are pleased ... of Defense (US Army) contract valued at over $2 ... diagnostic machine and technical support staffing. As an 8-A ... Business Administration (SBA), Medical Equipment is proud to support ... medical diagnostic equipment. The SBA 8-A certification is a ...
Breaking Medicine Technology:Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 2Report: Biopharma and Medical Device Companies Beat Historic Investment Returns 3Access Pharmaceuticals Featured On OncLive.com 2Access Pharmaceuticals Featured On OncLive.com 3Medical Equipment Solutions Corp. Awarded $2 Million contract To Service DoD 2
... , Feb. 10 CORD:USE Cord Blood Bank ... System, the fifth-largest public healthcare system in the nation, to ... global registry for patients in need of a potentially life-saving ... will allow CORD:USE to continue building the National Cord Blood ...
... , , ... Cell-Teva Joint Venture,(JV) announced today that the Data Monitoring Committee (DMC) ... of StemEx (called ExCell) and has recommended that the JV,continue to ... take place during Q2 2010. StemEx is being evaluated as a,therapeutic ...
Cached Medicine Technology:CORD:USE Cord Blood Bank Announces Partnership with Memorial Healthcare System 2Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma 2Data Monitoring Committee Recommends Continuation of Phase III Study of StemEx(R), a Cord Blood Stem Cell Product, for Leukemia and Lymphoma 3
This versatile convex array abdominal transducer is multi-frequency, offering 5 levels of fundamental frequencies in addition to 4 settings of Harmonic frequencies. This transducer provides superb im...
HST, versatile convex array abdominal transducer is multi-frequency, offering 5 levels of fundamental frequencies in addition to 4 settings of Harmonic frequencies. This transducer provides superb im...
... is ALOKAs answer to the ... Super High Density, versatile convex ... offering 5 levels of fundamental ... settings of Harmonic frequencies. This ...
The versatility of multiple imaging frequencies and a smaller transducer face make this transducer is perfect for intercostal imaging....
Medicine Products: